Basso L A, Santos D S, Shi W, Furneaux R H, Tyler P C, Schramm V L, Blanchard J S
Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
Biochemistry. 2001 Jul 27;40(28):8196-203. doi: 10.1021/bi010584x.
Purine salvage pathways are predicted to be present from the genome sequence of Mycobacterium tuberculosis. The M. tuberculosis deoD gene encodes a presumptive purine nucleoside phosphorylase (PNP). The gene was cloned, expressed, purified, and found to exhibit PNP activity. Purified M. tuberculosis PNP is trimeric, similar to mammalian PNP's but unlike the hexameric Escherichia coli enzyme. Immucillin-H is a rationally designed analogue of the transition state that has been shown to be a potent inhibitor of mammalian PNP's. This inhibitor also exhibits slow-onset inhibition of M. tuberculosis PNP with a rapid, reversible inhibitor binding (K(i) of 2.2 nM) followed by an overall dissociation constant (K(i)) of 28 pM, yielding a K(m)/K(i) value of 10(6). Time-dependent tight binding of the inhibitor occurs with a rate of 0.1 s(-)(1), while relaxation of the complex is slower at 1.4 x 10(-)(3) s(-)(1). The pH dependence of the K(i) value of immucillin-H to the M. tuberculosis PNP suggests that the inhibitor binds as the neutral, unprotonated form that is subsequently protonated to generate the tight-binding species. The M. tuberculosis enzyme demonstrates independent and equivalent binding of immucilin-H at each of the three catalytic sites, unlike mammalian PNP. Analysis of the components of immucillin-H confirms that the inhibition gains most of its binding energy from the 9-deazahypoxanthine group (K(is) of 0.39 microM) while the 1,4-dideoxy-1,4-iminoribitol binds weakly (K(is) of 2.9 mM). Double-inhibition studies demonstrate antagonistic binding of 9-deazahypoxanthine and iminoribitol (beta = 13). However, the covalent attachment of these two components in immucillin-H increases equilibrium binding affinity by a factor of >14 000 (28 pM vs 0.39 microM) compared to 9-deazahypoxanthine alone, and by a factor of >10(8) compared to iminoribitol alone (28 pM vs 2.9 mM), from initial velocity measurements. The structural basis for M. tuberculosis PNP inhibition by immucillin-H and by its component parts is reported in the following paper [Shi, W., Basso, L. A., Santos, D. S., Tyler, P. C., Furneaux, R. H., Blanchard, J. S., Almo, S. C., and Schramm, V. L. (2001) Biochemistry 40, 8204-8215].
根据结核分枝杆菌的基因组序列预测,其存在嘌呤补救途径。结核分枝杆菌的deoD基因编码一种推定的嘌呤核苷磷酸化酶(PNP)。该基因被克隆、表达、纯化,并发现具有PNP活性。纯化后的结核分枝杆菌PNP是三聚体,与哺乳动物的PNP相似,但与六聚体的大肠杆菌酶不同。免疫亲和素-H是一种经过合理设计的过渡态类似物,已被证明是哺乳动物PNP的有效抑制剂。这种抑制剂对结核分枝杆菌PNP也表现出缓慢起效的抑制作用,其抑制剂结合迅速且可逆(K(i)为2.2 nM),随后的总解离常数(K(i))为28 pM,K(m)/K(i)值为10(6)。抑制剂的时间依赖性紧密结合速率为0.1 s(-)(1),而复合物的解离则较慢,为1.4 x 10(-)(3) s(-)(1)。免疫亲和素-H对结核分枝杆菌PNP的K(i)值的pH依赖性表明,抑制剂以中性、未质子化的形式结合,随后质子化形成紧密结合的物种。与哺乳动物PNP不同,结核分枝杆菌的这种酶在三个催化位点中的每一个位点上对免疫亲和素-H都表现出独立且等效的结合。对免疫亲和素-H各组分的分析证实,抑制作用的大部分结合能来自9-脱氮次黄嘌呤基团(K(is)为0.39 microM),而1,4-二脱氧-1,4-亚氨基核糖醇的结合较弱(K(is)为2.9 mM)。双重抑制研究表明9-脱氮次黄嘌呤和亚氨基核糖醇存在拮抗结合(β = 13)。然而,与单独的9-脱氮次黄嘌呤相比,免疫亲和素-H中这两种组分的共价连接使平衡结合亲和力提高了>14000倍(28 pM对0.39 microM),与单独亚氨基核糖醇相比提高了>10(8)倍(28 pM对2.9 mM),这是通过初始速度测量得出的。后续论文[Shi, W., Basso, L. A., Santos, D. S., Tyler, P. C., Furneaux, R. H., Blanchard, J. S., Almo, S. C., and Schramm, V. L. (2001) Biochemistry 40, 8204 - 8215]报道了免疫亲和素-H及其各组分对结核分枝杆菌PNP抑制作用的结构基础。